Central Nervous System Agents in Medicinal Chemistry
Title:Acknowledgements to Reviewers
Volume: 18 Issue: 3
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, Acknowledgements to Reviewers, Central Nervous System Agents in Medicinal Chemistry 2018; 18 (3) . https://dx.doi.org/10.2174/187152491803181001155943
DOI https://dx.doi.org/10.2174/187152491803181001155943 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
18
2
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Oncogenic Signalling Networks and Polypharmacology as Paradigms to Cope with Cancer Heterogeneity
Current Proteomics Editorial [Hot Topic: GSK-3 in Health and Disease (Guest Editor: H. Eldar-Finkelman)]
Current Drug Targets Ibandronate in Benign Bone Disease
Reviews on Recent Clinical Trials Targeting Vascular Changes in Lesions in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
Central Nervous System Agents in Medicinal Chemistry Metabolic Syndrome the Gynecologist’s Approach
Current Women`s Health Reviews Diagnosis and Possible Use of Traditional Medicinal Plant to combat COVID-19
Coronaviruses <i>Uncaria rhynchophylla</i> and its Major Constituents on Central Nervous System: A Review on Their Pharmacological Actions
Current Vascular Pharmacology The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action
Current Genomics Group-Analysis of Resting-State fMRI Based on Bayesian Network: A Comparison of Three Virtual-Typical-Subject Methods
Neuroscience and Biomedical Engineering (Discontinued) Glycine Reuptake Inhibition as a New Therapeutic Approach in Schizophrenia: Focus on the Glycine Transporter 1 (GlyT1)
Current Pharmaceutical Design GHB, GBL and 1,4-BD Addiction
Current Pharmaceutical Design Nanoparticle Drug Delivery Systems: Recent Patents and Applications in Nanomedicine
Recent Patents on Nanomedicine Microwave-assisted Olefin Metathesis as Pivotal Step in the Synthesis of Bioactive Compounds
Current Medicinal Chemistry Soft Condensed Matter in Pharmaceutical Design
Current Pharmaceutical Design Clinical Drugs that Interact with St. Johns Wort and mplication in Drug Development
Current Pharmaceutical Design Structure Solution of Misfolded Conformations Adopted by Intrinsically Disordered Alzheimers Tau Protein
Protein & Peptide Letters Segmentation of Tissues from MRI Biomedical Images Using Kernel Fuzzy PSO Clustering Based Level Set Approach
Current Medical Imaging An Insight into Molecular Mechanisms and Novel Therapeutic Approaches in Epileptogenesis
CNS & Neurological Disorders - Drug Targets Structural Characterization of Amyloid β17-42 Dimer by Potential of Mean Force Analysis: Insights from Molecular Dynamics Simulations
Protein & Peptide Letters Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimers Disease
Current Neuropharmacology